Cell Therapeutics, Inc. (CTI) to Report Third Quarter Financial Results on October 30, 2012

  Cell Therapeutics, Inc. (CTI) to Report Third Quarter Financial Results on
                               October 30, 2012

PR Newswire

SEATTLE, Oct. 26, 2012

SEATTLE, Oct. 26, 2012 /PRNewswire/ --On Tuesday, October 30, 2012, at 8:30
a.m. Eastern/1:30 p.m. Central European/5:30 a.m. Pacific, members of Cell
Therapeutics, Inc.'s (CTI) (NASDAQ and MTA: CTIC) management team will host a
conference call to discuss the Company's 2012 third quarter achievements and
financial results.

Conference Call Numbers
Tuesday, October 30^th
8:30 a.m. Eastern/1:30 p.m. Central European/5:30 a.m. Pacific Time
1-877-941-2333 (US Participants)
1-480-629-9773 (International)
Call-back numbers for post-listening available at 11:30 a.m. Eastern:
1- 800-406-7325 (US Participants)
1- 303-590-3030 (International)
Passcode: 4572038 #

Live audio webcast at www.celltherapeutics.com will be archived for post
listening approximately two hours after call ends.

About Cell Therapeutics, Inc.

Headquartered in Seattle, CTI is a biopharmaceutical company committed to
developing an integrated portfolio of oncology products aimed at making cancer
more treatable. For additional information, please visit
www.CellTherapeutics.com.

Sign up for email alerts and get RSS feeds at our Web site,
http://www.CellTherapeutics.com/investors_alert

Media Contact:                      Investors Contact:
Dan Eramian                         Ed Bell
T: 206.272.4343                     T: 206.272.4345
C: 206.854.1200                     E: invest@ctiseattle.com
F: 206.272.4434                     www.celltherapeutics.com/investors
E: deramian@ctiseattle.com
www.celltherapeutics.com/press_room

SOURCE Cell Therapeutics, Inc.

Website: http://www.celltherapeutics.com
 
Press spacebar to pause and continue. Press esc to stop.